Cardiff Oncology Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $6.42 on 03/25/24, while the lowest price for the same duration was marked at $0.94 on 11/10/23.
52-week price history of CRDF Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Cardiff Oncology Inc’s current trading price is -62.93% away from its 52-week high, while its distance from the 52-week low is 153.19%. The stock’s price range during this period has spanned from $0.94 to $6.42. In the Healthcare sector, the Cardiff Oncology Inc’s shares surpassed a trading volume of approximately 0.88 million for the day, which was noticeably higher compared to the average daily volume of 9.0.59 million over the past three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Market Capitalization and Financial Performance: An In-Depth Look
Cardiff Oncology Inc (CRDF) has experienced a quarterly decline of -29.59% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 106.43M and boasts a workforce of 32 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.47, with a change in price of -2.79. Similarly, Cardiff Oncology Inc recorded 745,503 in trading volume during the last 100 days, posting a change of -53.97%.
Examining CRDF’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for CRDF stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.02.
CRDF Stock Stochastic Average
Today’s raw stochastic average for Cardiff Oncology Inc over the last 50 days is 28.24%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 58.27%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 32.55% and 26.51%, respectively.
CRDF Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. This year’s metric has recorded a Price increase of 60.81%. However, over the past six months, we’ve seen a weaker performance of 32.22%. The price of CRDF leaped by -3.64% over the last 30 days. And in the last five days, it has surged by 6.25%.
